InflaRx GAAP EPS of -€1.10

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

InflaRx GAAP EPS of -€1.10

To read the full story on Seeking Alpha, click here.

InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more InflaRx NV Charts.

InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more InflaRx NV Charts.

InflaRx NV News

InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024
Tuesday 30 April 2024 (2 days ago) • GlobeNewswire Inc.

InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
Wednesday 24 April 2024 (1 week ago) • GlobeNewswire Inc.

InflaRx Reports Full Year 2023 Results and Announces INF904 Development Plans
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.

InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
Tuesday 19 March 2024 (1 month ago) • GlobeNewswire Inc.

InflaRx Appoints Jan Medina as Head of Investor Relations
Thursday 22 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
Thursday 25 January 2024 (3 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 4 January 2024 (4 months ago) • Edgar (US Regulatory)

InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904
Thursday 4 January 2024 (4 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 6 November 2023 (6 months ago) • Edgar (US Regulatory)

InflaRx Announces First Patient Dosed in Phase III Trial with Vilobelimab in Pyoderma Gangrenosum
Monday 6 November 2023 (6 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 1 November 2023 (6 months ago) • Edgar (US Regulatory)

More InflaRx NV News Articles

Global Developments (PK)

FBEC Worldwide (PK)

Mullen Automotive

Atacama Resources (PK)

NaturalShrimp (QB)

NioCorp Developments

Branded Legacy (PK)

Fannie Mae (QB)

MicroCloud Hologram

International Star (PK)

Tonner One World (PK)

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions